VMI
MIST icon

VHCP Management III’s Milestone Pharmaceuticals MIST Stock Holding History

VHCP Management III’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$33.1M Hold
2,066,529
– – 6.57% 3
2019
Q3 		$38.5M Hold
2,066,529
– – 23.79% 1
2019
Q2 		$56.1M Buy
+2,066,529
New +$42.6M 26.2% 1

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VHCP Management III's MIST Position: Q4 2019 in Review

VHCP Management III held its Milestone Pharmaceuticals (MIST) position steady in Q4 2019 at 2,066,529 shares worth $33.1M. The position accounts for 6.57% of the portfolio, ranked #3.

VHCP Management III first reported a position in MIST in Q2 2019 and has held it in 3 quarters since. The position peaked at $56.1M in Q2 2019. 25 funds tracked by Wall St. Rank hold MIST as of Q4 2019.

  • VHCP Management III held 2,066,529 shares of Milestone Pharmaceuticals worth $33.1M as of Q4 2019.
  • VHCP Management III left its Milestone Pharmaceuticals share count unchanged in Q4 2019.
  • Milestone Pharmaceuticals made up 6.57% of VHCP Management III's portfolio in Q4 2019, its #3 holding.
  • VHCP Management III first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 3 quarters since.
  • VHCP Management III's Milestone Pharmaceuticals position peaked at $56.1M in Q2 2019.
  • 25 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.